Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions
出版年份 2016 全文链接
标题
Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions
作者
关键词
-
出版物
PPAR Research
Volume 2016, Issue -, Pages 1-9
出版商
Hindawi Limited
发表日期
2016-12-29
DOI
10.1155/2016/6517313
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner
- (2016) Antonio Simone Laganà et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives
- (2016) Vaclav Vetvicka et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema
- (2016) Chihiro Ozawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR- Pathway
- (2016) S. Beyaz et al. CLINICAL CANCER RESEARCH
- Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency
- (2016) Mohammad Zarei et al. DIABETES
- The PPARα Agonist Fenofibrate Improves the Musculoskeletal Effects of Exercise in Ovariectomized Rats
- (2016) Mats Peder Mosti et al. ENDOCRINOLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives
- (2016) Cristiana Paul et al. GYNECOLOGICAL ENDOCRINOLOGY
- Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α
- (2016) Terry D. Hinds et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
- (2016) Giovanni Sarnelli et al. PLoS One
- High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine
- (2016) Julie Tomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer
- (2016) Simone Polvani WORLD JOURNAL OF GASTROENTEROLOGY
- How to Achieve High-Quality Oocytes? The Key Role of Myo-Inositol and Melatonin
- (2016) Salvatore Giovanni Vitale et al. International Journal of Endocrinology
- Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
- (2016) Daniela Rovito et al. Oncotarget
- PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions
- (2016) X Wang et al. Oncogenesis
- Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease
- (2015) Vincenza Sofo et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation
- (2015) Emma Barroso et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells
- (2015) Xi Fang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dietary -Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPAR
- (2015) S. Das Gupta et al. Cancer Prevention Research
- HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice
- (2015) Avik Roy et al. Cell Metabolism
- PPARα regulates tumor progression, foe or friend?
- (2015) Jiaming Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Early investigational drugs targeting PPAR-α for the treatment of metabolic disease
- (2015) Zhong-Min Liu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
- (2015) Xiaoling Wang et al. JOURNAL OF CONTROLLED RELEASE
- Ligand-activated PPARδ upregulates α-smooth muscle actin expression in human dermal fibroblasts: A potential role for PPARδ in wound healing
- (2015) Sun Ah Ham et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity
- (2015) Marta Toral et al. JOURNAL OF HYPERTENSION
- Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
- (2015) Hyung Kyu Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- AMP-Activated Protein Kinase Interacts with the Peroxisome Proliferator-Activated Receptor Delta to Induce Genes Affecting Fatty Acid Oxidation in Human Macrophages
- (2015) Marina Kemmerer et al. PLoS One
- Establishing the Role of PPARβ/δ in Carcinogenesis
- (2015) Jeffrey M. Peters et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- PPARαIs Required for PPARδAction in Regulation of Body Weight and Hepatic Steatosis in Mice
- (2015) Wojciech G. Garbacz et al. PPAR Research
- Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer
- (2015) Karthic Chandran et al. Oncotarget
- PPARα induces cell apoptosis by destructing Bcl2
- (2015) Jiaming Gao et al. Oncotarget
- The Pleiotropic Effects of Vitamin D in Gynaecological and Obstetric Diseases: An Overview on a Hot Topic
- (2015) Francesca Colonese et al. Biomed Research International
- Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway
- (2015) Ning Zhang et al. Oncotarget
- Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
- (2014) Limei Wang et al. BIOCHEMICAL PHARMACOLOGY
- Polyyne Hybrid Compounds from Notopterygium incisum with Peroxisome Proliferator-Activated Receptor Gamma Agonistic Effects
- (2014) Xin Liu et al. JOURNAL OF NATURAL PRODUCTS
- Regulation of lipoprotein lipase by Angptl4
- (2014) Wieneke Dijk et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism
- (2013) Emmanuelle Roche et al. CELLULAR SIGNALLING
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression
- (2013) Yao-Jen Liang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator-Activated Receptor
- (2013) K. Wejksza et al. JOURNAL OF IMMUNOLOGY
- Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
- (2013) Francisco A. Monsalve et al. MEDIATORS OF INFLAMMATION
- Role of Peroxisome Proliferator-Activated Receptorβ/δand B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells
- (2013) Jeffrey D. Coleman et al. PPAR Research
- PPAR Agonists Target Aromatase Via Both PGE2 and BRCA1
- (2012) O. Margalit et al. Cancer Prevention Research
- Pioglitazone, a PPAR Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1
- (2012) K. Subbaramaiah et al. Cancer Prevention Research
- Stromal adipocyte PPARγ protects against breast tumorigenesis
- (2012) Graham Skelhorne-Gross et al. CARCINOGENESIS
- Inhibitory effect of PPARγ on NR0B1 in tumorigenesis of lung adenocarcinoma
- (2012) YOSHIYUKI SUSAKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The PPARδ ligand L-165041 inhibits vegf-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ
- (2012) Jin-Hee Park et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells
- (2012) Marianna Terrasi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Development of Subcutaneous Sarcomas in Rodents Exposed to Peroxisome Proliferators Agonists
- (2012) Ingrid M. Pruimboom-Brees et al. TOXICOLOGIC PATHOLOGY
- Inhibition of PPAR in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis
- (2011) L. Wu et al. BLOOD
- PPARs and Lipid Ligands in Inflammation and Metabolism
- (2011) Gregory S. Harmon et al. CHEMICAL REVIEWS
- A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice
- (2011) R. A. Ngala et al. DIABETES OBESITY & METABOLISM
- Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
- (2011) Jang Hyun Choi et al. NATURE
- Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
- (2009) Jean-Charles Fruchart ATHEROSCLEROSIS
- The effect of PPAR-α agonism on apolipoprotein metabolism in humans
- (2009) Ashish Shah et al. ATHEROSCLEROSIS
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats
- (2008) B.-C. Yu et al. CARDIOVASCULAR RESEARCH
- Regulation of Peroxisome Proliferator–Activated Receptor-α by MDM2
- (2008) Lakshmi Gopinathan et al. TOXICOLOGICAL SCIENCES
- Regulation of Peroxisome Proliferator-Activated Receptors by E6-Associated Protein
- (2008) Lakshmi Gopinathan et al. PPAR Research
- Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
- (2008) Mark A. Deeg et al. PPAR Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started